Literature DB >> 10749936

Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs.

B P Haines1, R B Voyle, P D Rathjen.   

Abstract

Although many growth factors and cytokines have been shown to be localized within the cell and nucleus, the mechanism by which these molecules elicit a biological response is not well understood. The cytokine leukemia inhibitory factor (LIF) provides a tractable experimental system to investigate this problem, because translation of alternatively spliced transcripts results in the production of differentially localized LIF proteins, one secreted from the cell and acting via cell surface receptors and the other localized within the cell. We have used overexpression analysis to demonstrate that extracellular and intracellular LIF proteins can have distinct cellular activities. Intracellular LIF protein is localized to both nucleus and cytoplasm and when overexpressed induces apoptosis that is inhibited by CrmA but not Bcl-2 expression. Mutational analysis revealed that the intracellular activity was independent of receptor interaction and activation and reliant on a conserved leucine-rich motif that was not required for activation of cell surface receptors by extracellular protein. This provides the first report of alternate intracellular and extracellular cytokine activities that result from differential cellular localization of the protein and are mediated by spatially distinct motifs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749936      PMCID: PMC14853          DOI: 10.1091/mbc.11.4.1369

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  85 in total

1.  The role of leukemia inhibitory factor in skeletal muscle regeneration.

Authors:  J B Kurek; J J Bower; M Romanella; F Koentgen; M Murphy; L Austin
Journal:  Muscle Nerve       Date:  1997-07       Impact factor: 3.217

2.  Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.

Authors:  P Mountford; B Zevnik; A Düwel; J Nichols; M Li; C Dani; M Robertson; I Chambers; A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

3.  The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro.

Authors:  D A Jans; L J Briggs; S E Gustin; P Jans; S Ford; I G Young
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

4.  Characterization and immunolocalization of bovine N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase.

Authors:  K G Mullis; R H Kornfeld
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition.

Authors:  T Komiyama; C A Ray; D J Pickup; A D Howard; N A Thornberry; E P Peterson; G Salvesen
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

6.  Prevention of vertebrate neuronal death by the crmA gene.

Authors:  V Gagliardini; P A Fernandez; R K Lee; H C Drexler; R J Rotello; M C Fishman; J Yuan
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

7.  Are LIF and related cytokines functionally equivalent?

Authors:  C Piquet-Pellorce; L Grey; A Mereau; J K Heath
Journal:  Exp Cell Res       Date:  1994-08       Impact factor: 3.905

8.  Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets.

Authors:  F Amalric; G Bouche; H Bonnet; P Brethenou; A M Roman; I Truchet; N Quarto
Journal:  Biochem Pharmacol       Date:  1994-01-13       Impact factor: 5.858

9.  The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.

Authors:  R C Robinson; L M Grey; D Staunton; H Vankelecom; A B Vernallis; J F Moreau; D I Stuart; J K Heath; E Y Jones
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

10.  Receptor-mediated nuclear translocation of growth hormone.

Authors:  P E Lobie; H Mertani; G Morel; O Morales-Bustos; G Norstedt; M J Waters
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

View more
  10 in total

1.  Subcellular localization of CrmA: identification of a novel leucine-rich nuclear export signal conserved in anti-apoptotic serpins.

Authors:  Jose A Rodriguez; Simone W Span; Frank A E Kruyt; Giuseppe Giaccone
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

2.  HOXA10 expression is decreased in endometrium of women with adenomyosis.

Authors:  Catha P Fischer; Umit Kayisili; Hugh S Taylor
Journal:  Fertil Steril       Date:  2010-11-10       Impact factor: 7.329

3.  p53 Regulates LIF expression in human medulloblastoma cells.

Authors:  Euan W Baxter; Jo Milner
Journal:  J Neurooncol       Date:  2009-11-12       Impact factor: 4.130

4.  TNFalpha in the pathogenesis of diabetes-induced embryopathies: functions and targets.

Authors:  Arkady Torchinsky; Vladimir Toder
Journal:  Rev Diabet Stud       Date:  2008-02-10

Review 5.  Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells.

Authors:  Shigetsugu Hatakeyama
Journal:  JAKSTAT       Date:  2012-07-01

6.  Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA.

Authors:  Toru Hisaka; Alexis Desmoulière; Jean-Luc Taupin; Sophie Daburon; Véronique Neaud; Nathalie Senant; Jean-Frédéric Blanc; Jean-François Moreau; Jean Rosenbaum
Journal:  Comp Hepatol       Date:  2004-11-26

Review 7.  Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis.

Authors:  Shu-Chen Liu; Yu-Sun Chang
Journal:  Mol Cell Oncol       Date:  2014-07-15

8.  Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK/PXN signaling.

Authors:  Shu-Chen Liu; Tien Hsu; Yu-Sun Chang; An-Ko Chung; Shih Sheng Jiang; Chun-Nan OuYang; Chiou-Hwa Yuh; Chuen Hsueh; Ya-Ping Liu; Ngan-Ming Tsang
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

Review 9.  Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Authors:  Ewa Wrona; Piotr Potemski; Francesco Sclafani; Maciej Borowiec
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-25       Impact factor: 4.291

Review 10.  Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.

Authors:  Megan M Jorgensen; Pilar de la Puente
Journal:  Biomolecules       Date:  2022-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.